Nantahala Capital Management - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 62 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2021$773,000
-53.0%
50,0000.0%0.02%
-54.2%
Q1 2021$1,646,00050,0000.05%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$29,242,00011.52%
Nan Fung Group Holdings Ltd 1,166,952$18,041,0005.60%
Novo Holdings A/S 4,503,991$69,632,0003.09%
Vivo Capital, LLC 3,871,291$59,850,0002.59%
Sofinnova Investments, Inc. 2,754,437$42,584,0002.45%
Ally Bridge Group (NY) LLC 412,267$6,374,0001.58%
Samsara BioCapital, LLC 737,459$11,401,0001.41%
Board of Trustees of The Leland Stanford Junior University 719,546$11,125,0001.04%
RA Capital Management 2,378,325$36,769,0000.59%
Rock Springs Capital Management LP 1,619,248$25,034,0000.50%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders